ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for LXA4 can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated....ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for LXA4 can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits...ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for LXA4 can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits include all the necessary reagents to coat your own plates and run your assay with maximum flexibility. Coated ELISA kits...
ELISA kits are commonly used to measure soluble biomarkers across a variety of research areas. ELISA kits for LXA4 can be quantified in various samples, including plasma, serum.
Invitrogen ELISA kits exist in two formats: Uncoated and Coated. Uncoated ELISA kits include all the necessary reagents to coat your own plates and run your assay with maximum flexibility. Coated ELISA kits are ready-to-use and quality tested for sensitivity, specificity, precision and lot-to-lot consistency.
靶标信息
Lipoxin A4 (LXA4) is a potent lipid mediator that plays a crucial role in resolving inflammation and promoting tissue repair. It is a member of the lipoxin family of eicosanoids, which are derived from arachidonic acid metabolism. LXA4 is primarily produced by leukocytes, including neutrophils, monocytes, and macrophages, in response to inflammatory stimuli. LXA4 exerts its anti-inflammatory and pro-resolving effects by binding to specific receptors on target cells, including ALX/FPR2 and GPR32. These receptors are expressed on various immune cells, endothelial cells, and epithelial cells, and their activation leads to the inhibition of pro-inflammatory signaling pathways and the induction of tissue repair processes. The structure of LXA4 is characterized by a 5S, 6R, 15S-trihydroxy-7E, 9E, 11Z, 13E-eicosatetraenoic acid backbone, with a hydroxyl group at position 17 and a carboxylic acid group at position 16. LXA4 is a stereoisomer of another lipoxin, LXB4, which has an opposite configuration at position 5 and a reduced hydroxyl group at position 15.